Search research articles
Contact Us
Filters
Showing results (21-30 of 288) with videos related to
Page
of 29
Sort By:
Journal of the American Heart Association
|
May 25, 2021
Continuing to Advance the Venous Agenda: Long-Term Insights From the CAVA Trial
Andrea Obi, Geoffrey D Barnes
JAMA Network Open
|
May 26, 2026
COX-2-Selective NSAIDs With DOACs in Atrial Fibrillation-Analgesic Safety via Antithrombotic Stewardship
Kelly Rudd, Geoffrey D Barnes
Annals of Internal Medicine
|
September 23, 2016
Web Exclusives. Annals for Hospitalists Inpatient Notes - Oral Anticoagulation for the Hospitalist-Expanded Choices Improve Patient-Centered Care
Geoffrey D Barnes, David Paje
Research and Practice in Thrombosis and Haemostasis
|
February 4, 2021
Response: Patient and caregiver engagement in venous thromboembolism research
Geoffrey D Barnes, Mary Cushman
Vascular Medicine (London, England)
|
April 6, 2019
Venous thromboembolism: A clinician update
Maya Serhal, Geoffrey D Barnes
International Journal of Cardiology. Heart & Vasculature
|
August 9, 2022
Barriers to stroke prevention in Atrial Fibrillation: Insights from the global anticoagulation Roundtable
Geoffrey D Barnes, Gregory Piazza,
Journal of the American Heart Association
|
November 6, 2023
Direct Oral Anticoagulants Versus Vitamin K Antagonist in Elderly Patients With Atrial Fibrillation: Sometimes Less Is More, but Sometimes More Is More
Arthur Allen, Geoffrey D Barnes
The Medical Clinics of North America
|
June 11, 2025
Pulmonary Embolism Response Teams
Juan Caceres, Geoffrey D Barnes
Journal of the American College of Cardiology
|
October 30, 2020
Antithrombotic Management of Venous Thromboembolism: JACC Focus Seminar
Elizabeth Renner, Geoffrey D Barnes
The American Journal of Medicine
|
May 27, 2022
The Reply
George Cholack, Geoffrey D Barnes
Page
of 29
Search research articles
Search
Showing results (21-30 of 288) with videos related to
Sort By:
Page
of 29
Journal of the American Heart Association
|
May 25, 2021
Continuing to Advance the Venous Agenda: Long-Term Insights From the CAVA Trial
Andrea Obi, Geoffrey D Barnes
JAMA Network Open
|
May 26, 2026
COX-2-Selective NSAIDs With DOACs in Atrial Fibrillation-Analgesic Safety via Antithrombotic Stewardship
Kelly Rudd, Geoffrey D Barnes
Annals of Internal Medicine
|
September 23, 2016
Web Exclusives. Annals for Hospitalists Inpatient Notes - Oral Anticoagulation for the Hospitalist-Expanded Choices Improve Patient-Centered Care
Geoffrey D Barnes, David Paje
Research and Practice in Thrombosis and Haemostasis
|
February 4, 2021
Response: Patient and caregiver engagement in venous thromboembolism research
Geoffrey D Barnes, Mary Cushman
Vascular Medicine (London, England)
|
April 6, 2019
Venous thromboembolism: A clinician update
Maya Serhal, Geoffrey D Barnes
International Journal of Cardiology. Heart & Vasculature
|
August 9, 2022
Barriers to stroke prevention in Atrial Fibrillation: Insights from the global anticoagulation Roundtable
Geoffrey D Barnes, Gregory Piazza,
Journal of the American Heart Association
|
November 6, 2023
Direct Oral Anticoagulants Versus Vitamin K Antagonist in Elderly Patients With Atrial Fibrillation: Sometimes Less Is More, but Sometimes More Is More
Arthur Allen, Geoffrey D Barnes
The Medical Clinics of North America
|
June 11, 2025
Pulmonary Embolism Response Teams
Juan Caceres, Geoffrey D Barnes
Journal of the American College of Cardiology
|
October 30, 2020
Antithrombotic Management of Venous Thromboembolism: JACC Focus Seminar
Elizabeth Renner, Geoffrey D Barnes
The American Journal of Medicine
|
May 27, 2022
The Reply
George Cholack, Geoffrey D Barnes
Page
of 29